We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
B Cell Tolerance and Targeted Therapies in SLE.
- Authors
Parodis, Ioannis; Long, Xuan; Karlsson, Mikael C. I.; Huang, Xin
- Abstract
Systemic Lupus Erythematosus (SLE) is a chronic systemic autoimmune disease of high clinical and molecular heterogeneity, and a relapsing-remitting pattern. The disease is currently without cure and more prevalent in women. B cell tolerance and production of autoantibodies are critical mechanisms that drive SLE pathophysiology. However, how the balance of the immune system is broken and how the innate and adaptive immune systems are interacting during lupus-specific autoimmune responses are still largely unknown. Here, we review the latest knowledge on B cell development, maturation, and central versus peripheral tolerance in connection to SLE and treatment options. We also discuss the regulation of B cells by conventional T cells, granulocytes, and unconventional T cells, and how effector B cells exert their functions in SLE. We also discuss mechanisms of action of B cell-targeted therapies, as well as possible future directions based on current knowledge of B cell biology.
- Subjects
B cells; T cells; SYSTEMIC lupus erythematosus; CYTOLOGY; CELL physiology; AUTOIMMUNE diseases
- Publication
Journal of Clinical Medicine, 2023, Vol 12, Issue 19, p6268
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm12196268